Infinitus Systems secured $51.5 million Series C funding

Infinitus Systems secured $51.5 million Series C funding

Infinitus Systems which is a Healthcare AI communication company has secured $51.5 million in the series C funding from Andreessen Horowitz (a16z). Other participants were Kleiner Perkins, Memorial Hermann Health System, Coatue, and Google ventures (GV).

Please login to comment on this Post

Most Visited Posts

1

Health November 18, 2024

Yazen Health Secures €19.5M to Transform Obesity Treatment Across Europe

Yazen Health Secures €19.5M to Transform...

2

Sports August 10, 2023

Exploring the World of BGMI MOD APK: Unleashing the Power of Customization

BGMI MOD APK has taken the gaming community by...

3

Health April 25, 2024

Medical Consulting Services USA

MIPS (Merit-based Incentive Payment System)...

4

April 18, 2024

How Does Sirolimus Prevent Organ Rejection?

Sirolimus, also known as rapamycin, is an immunosuppressant medication that belongs to a class of drugs called mTOR inhibitors. It works by suppressing the activity of the immune system, thereby preventing it from attacking and rejecting transplanted organs.